PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25920F0023Pharmaceutical destruction and reverse — Returns 'R' Us, Inc

PoP ended Oct 8, 2020 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Network Contract Office 19 (36C259)

Awarding office

Returns 'R' Us, Inc

Recipient

Oct 8, 2020

PoP end

$-80,809.37

Obligated

$296K

Potential

493110

NAICS

S299

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Returns 'R' Us, Inc — $90

Contract facts

Federal

Contract number36C25920F0023

Also listed as36C259-20-F-0023

Also listed as36W79718D0002-36C25920F0023

AgencyNetwork Contract Office 19 (36C259)

Awarding officeNetwork Contract Office 19 (36C259)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentReturns 'R' Us, Inc

CAGE1PUE0

UEID4VCRL38H9C9

NAICS493110

No full NAICS 493110 intel page yet. Browse NAICS intelligence

PSCS299

Parent IDIQ / IDV36W79718D0002

Place of performanceAURORA CO

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition After Exclusion Of Sources

PoP startOct 9, 2019

PoP end (current)Oct 8, 2020

Obligated$-80,809.37

Current value$296K

Potential value$296K

PHARMACEUTICAL DESTRUCTION AND REVERSE DISTRIBUTION is a federal award for Network Contract Office 19 (36C259) held by Returns 'R' Us, Inc. Estimated value $296K ($-80,809.37 obligated). Current period of performance ends Oct 8, 2020. Place of performance: AURORA CO.

PHARMACEUTICAL DESTRUCTION AND REVERSE DISTRIBUTION

Recompete timing

Public

● Past PoP end (2143 days ago)

Current PoP ended Oct 8, 2020 (2143 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C25920F0023?

36C25920F0023 (Pharmaceutical destruction and reverse) is a Network Contract Office 19 (36C259) award with a potential value of $296K, currently held by Returns 'R' Us, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C259-20-F-0023?

36C259-20-F-0023 is the dashed form of PIID 36C25920F0023 (Pharmaceutical destruction and reverse), held by Returns 'R' Us, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25920F0023?

Network Contract Office 19 (36C259) awarded 36C25920F0023 to Returns 'R' Us, Inc (potential $296K).

Who is the incumbent on 36C25920F0023?

Returns 'R' Us, Inc is the incumbent. The current period of performance ends Oct 8, 2020.

When does Returns 'R' Us, Inc’s 36C25920F0023 come up for recompete?

SCOUT tracks a period-of-performance end of Oct 8, 2020. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Sep 13, 2023 · refreshed monthly